CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- 4 Planned sale EVP, Chief Commercial Officer sold 3,474 shares at an average $448.37 ($1,557,649)
- 4 Planned sale EVP Chief R&D sold 2,851 shares at an average $455.89 ($1,299,746)
- 4 Open-market sale EVP, Chief Commercial Officer sold 1,396 shares at an average $453.27 ($632,759)
- 4 Open-market sale EVP, Chief Financial Officer sold 2,274 shares at an average $453.27 ($1,030,727)
- 4 Open-market sale Chief Executive Officer sold 6,979 shares at an average $453.27 ($3,163,346)
- 4 Open-market sale CSO & EVP, Head of Research sold 1,396 shares at an average $453.27 ($632,759)
- 4 Planned sale Director sold 11,250 shares at $450.00 ($5,062,500)
- 4 Planned sale Director sold 31,448 shares at an average $436.58 ($13,729,536)
- 4 Grant or award CSO & EVP, Head of Research acquired 7,763 shares (grant or award)
- 4 Planned sale Chief Executive Officer sold 50,937 shares at an average $305.00 ($15,535,784)
- 4 Planned sale Director sold 11,250 shares at an average $277.71 ($3,124,217)
- 4 Gift Chief Executive Officer gave 8,376 shares (gift)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Grant or award Director acquired 775 shares (grant or award)
- 4 Open-market buy Director bought 36 shares at an average $287.85 ($10,363)
- 4 Grant or award Director acquired 775 shares (grant or award)
Page 4 of 47 · 936 filings